Latest Press Releases

Derm-biome Pharmaceuticals' Topical Therapy Shows Positive Results in Preclinical Skin Cancer Trial: Drug Prevents the Development of Precancerous Skin Conditions and Treats Existing Skin Cancers With No Observable Side Effects

VANCOUVER, British Columbia, April 17, 2024 (GLOBE NEWSWIRE) -- The rates of precancerous skin conditions and skin cancers are soaring in many parts of the world. Actinic keratosis (AK) is the most common form of precancer, with over 40 ...

London Research & Pharmaceuticals presents the Advancement of LRP-661, their Oral Cannabidiol Sulphate Drug Candidate at the Prestigious Epilepsy Therapies & Diagnostics Development (ETDD) XVII Conference in Miami

LONDON, Ontario, April 15, 2024 (GLOBE NEWSWIRE) -- London Research & Pharmaceuticals has recently publicized data about its lead compound LRP-661 or Cannabidiol sulphate (CBDS), highlighting its safety, efficacy, bioavailability, and ...

In'Tech Expands Regulatory Affairs Initiative Globally to Support Its Customers Worldwide

Tania Shammo Appointed Director of Global Regulatory Affairs & Quality Assurance. MEMPHIS, Tenn. , Nov. 12, 2019 /PRNewswire-PRWeb/ -- In'Tech Medical SAS ( http://www.intech-medical.com ), the leader in contract manufacturing of orthopedic ...

Mercy Medical Center Nationally Recognized With An 'A' For the Fall 2019 Leapfrog Hospital Safety Grade

Mercy Medical Center has been awarded an 'A' in the fall 2019 Leapfrog Hospital Safety Grade, a national distinction recognizing Mercy's achievements protecting patients from harm and providing safer health care. BALTIMORE , Nov. 12, 2019 ...

Lantern Phrama Selects REPROCELL Inc., for Drug Screening and Biomarker Discovery Services

Lantern Pharma a clinical stage oncology biotech leveraging A.I. and machine learning genomics company has selected REPROCELL Inc. to provide drug screening and drug sensitivity services. BELTSVILLE, Md. , Nov. 12, 2019 /PRNewswire-PRWeb/ ...

Michael A. Munz, MD, is being recognized by Continental Who's Who

VERO BEACH, Fla. , Nov. 11, 2019 /PRNewswire/ -- Michael A. Munz , MD, is being recognized by Continental Who's Who as a Pinnacle Lifetime Achiever in the field of Medicine in recognition of his role as a Neuro-Spine Surgeon at Veuro Neuro ...

Opioid Justice Team: Ad Hoc Committee for babies born opioid-dependent now represented in Purdue bankruptcy proceedings

Attorneys representing an Ad Hoc Committee for Neo-Natal Abstinence Syndrome (NAS) babies and children filed a statement before U.S. Bankruptcy Court Judge Robert Drain in White Plains, NY notifying the Purdue debtors that the needs of the most ...

Leslie W. Hardware, MD is being recognized by Continental Who's Who

SILVER SPRINGS, Md. , Nov. 11, 2019 /PRNewswire/ -- Leslie W. Hardware, MD is being recognized by Continental Who's Who as a Pinnacle Lifetime Achiever in the field of medicine as an emergency medical physician. Dr. Hardware is a board ...

Young Innovations Announces Acquisition of PuraGraft

ALGONQUIN, Ill. , Nov. 11, 2019 /PRNewswire/ -- Young Innovations, a leading global supplier of dental products, today announced the acquisition of PuraGraft, LLC. Based in Kingwood, TX , PuraGraft is a leading supplier of biomaterial ...

Wet Age-Related Macular Degeneration Market by Product, by Distribution Channel, by Age Group, by Route of Administration, by End User, by Geography Global Market Size, Share, Development, Growth, and Demand Forecast, 2014-2024

NEW YORK , Nov. 11, 2019 /PRNewswire/ -- Wet Age-Related Macular Degeneration (AMD) Market by Product (Lucentis, Eylea, Avastin), by Distribution Channel (Direct, Indirect), by Age Group (Above 80 Years, 6080 Years, 4059 Years), by Route of ...

Press Releases

Premium Press Releases »

Derm-biome Pharmaceuticals' Topical Therapy Shows Positive Results in Preclinical Skin Cancer Trial: Drug Prevents the Development of Precancerous Skin Conditions and Treats Existing Skin Cancers With No Observable Side Effects

London Research & Pharmaceuticals presents the Advancement of LRP-661, their Oral Cannabidiol Sulphate Drug Candidate at the Prestigious Epilepsy Therapies & Diagnostics Development (ETDD) XVII Conference in Miami

Press Releases »

In'Tech Expands Regulatory Affairs Initiative Globally to Support Its Customers Worldwide

Mercy Medical Center Nationally Recognized With An 'A' For the Fall 2019 Leapfrog Hospital Safety Grade

Lantern Phrama Selects REPROCELL Inc., for Drug Screening and Biomarker Discovery Services

Michael A. Munz, MD, is being recognized by Continental Who's Who

Opioid Justice Team: Ad Hoc Committee for babies born opioid-dependent now represented in Purdue bankruptcy proceedings

Leslie W. Hardware, MD is being recognized by Continental Who's Who

Young Innovations Announces Acquisition of PuraGraft

Wet Age-Related Macular Degeneration Market by Product, by Distribution Channel, by Age Group, by Route of Administration, by End User, by Geography Global Market Size, Share, Development, Growth, and Demand Forecast, 2014-2024

Heart to Heart Hospice Honors Our Nation's Veterans by Meeting Their Unique Needs

Windsor Care Centers Participate in National Compliance and Ethics Week for Third Time

Therapy market is projected to attain a size of $1,083.2 million by 2024, growing from $714.4 million in 2018

PRP Science Expands Product Offering to Include FDA Approved Products and Devices

NKMax America Announces Executive Advisory Board

Medindia Newsletters